Publications
Unitaid’s online library includes, among other things, stories about our impact, summaries of our grant portfolios, technical reports and resolutions from the Unitaid Board.
Find a Document
February 2023
Unitaid investment in Pre-Exposure Prophylaxis (PrEP), Wits Reproductive Health and HIV Institute (Wits RHI) and Fiotec, Joint Portfolio Level End-of-Project Evaluation, Executive Summary
Document Type
Evaluations
January 2023
Unitaid investment in Pre-Exposure Prophylaxis (PrEP), Wits Reproductive Health and HIV Institute (Wits RHI) and Fiotec, Joint Portfolio Level End-of-Project Evaluation, Final Report
Document Type
Evaluations
December 2022
Overview of mpox antivirals and diagnostics landscape
Document Type
Technology Landscape
December 2022
R23-2022-e Extension of investments in Unitaid’s COVID-19 Test-and-Treat and Medical Oxygen Portfolios
Document Type
e-Resolutions
December 2022
R22-2022-e HCV Combination Prevention in PWID and Prisoners Project (HEPC3P)
Document Type
e-Resolutions
December 2022
R21-2022-e Catalyse uptake of Under-utilised Tools & Treatment Simplification for HEPC (CUTTS HEPC)
Document Type
e-Resolutions
December 2022
R20-2022-e Innovate, Involve, Inspire: Preventing Hepatitis C Through Community-Led Harm Reduction
Document Type
e-Resolutions
December 2022
Joint Portfolio End-of-grant evaluation. Supporting the use of TRIPS Flexibilities
Document Type
Evaluations
December 2022
EB41/R3 – Extension of the invitation to Japan to occupy the temporary Executive Board seat
Document Type
Resolutions
June 2022
EB40/R2 – Approval of key performance indicators for the 2023 – 2027 strategic period
Document Type
Resolutions
December 2021
Unitaid 2017-2021 Strategy Review, Management Response, Dec 2021
Document Type
Evaluations
December 2021
Unitaid 2017-2021 Strategy Review, Final Report, Vol 2, Annexes
Document Type
Evaluations
December 2021
Unitaid 2017-202 Strategy Review, Final Report, Vol 1, Main report
Document Type
Evaluations
December 2022
R23-2022-e Extension of investments in Unitaid’s COVID-19 Test-and-Treat and Medical Oxygen Portfolios
Document Type
e-Resolutions
December 2022
R22-2022-e HCV Combination Prevention in PWID and Prisoners Project (HEPC3P)
Document Type
e-Resolutions
December 2022
R21-2022-e Catalyse uptake of Under-utilised Tools & Treatment Simplification for HEPC (CUTTS HEPC)
Document Type
e-Resolutions
December 2022
R20-2022-e Innovate, Involve, Inspire: Preventing Hepatitis C Through Community-Led Harm Reduction
Document Type
e-Resolutions
December 2022
EB41/R3 – Extension of the invitation to Japan to occupy the temporary Executive Board seat
Document Type
Resolutions
December 2022
EB41/R1 – Area for Intervention: “Mitigating antimalarial drug resistance”
Document Type
Resolutions
December 2022
R19-2022-e Calendar of Board and Committee meetings for 2023
Document Type
e-Resolutions
August 2022
R18-2022-e Amended Calendar of Board and Committee meetings for 2022
Document Type
e-Resolutions
August 2022
R17-2022-e Cost Extension for the Project ‘Better Access to Treatment for Paediatric MDR-TB (BENEFIT Kids)’
Document Type
e-Resolutions
August 2022
R16-2022-e DRIVEDX4TB: Accelerating Tools to Drive Tuberculosis Detection
Document Type
e-Resolutions
August 2022
R15-2022-e START 4-All: Start Taking Action for TB Diagnosis Project
Document Type
e-Resolutions
June 2016
Thematic Narrative for Reproductive, Maternal, Newborn and Child Health (RMNCH)
Document Type
November 2015
Strategic narrative: Hepatitis C in the context of co-infection with HIV
Document Type
June 2022
Unitaid on the cutting-edge: long-acting medicines to transform HIV care
Document Type
Infographics
May 2022
Unitaid Advancing tools and treatments to improve the health of women and girls worldwide
Document Type
Infographics
September 2018
Impact story: Expanding access to next generation drug-resistant tuberculosis treatment
Document Type
Impact stories
June 2018
Impact story: Accelerating access to seasonal malaria chemoprevention
Document Type
Impact stories
June 2018
Impact story: Early-infant diagnosis of HIV using point-of-care technologies
Document Type
Impact stories
December 2022
Overview of mpox antivirals and diagnostics landscape
Document Type
Technology Landscape
December 2022
Joint Portfolio End-of-grant evaluation. Supporting the use of TRIPS Flexibilities
Document Type
Evaluations
September 2022
Next Generation Pulse Oximeters Technology and Market Landscape
Document Type
Market Landscape, Technology Landscape
August 2022
Paediatric Tuberculosis Portfolio Joint End-of-Grant Evaluation Report
Document Type
Evaluations
August 2022
Malaria Diagnostics Market and Technology Landscape
Document Type
Market Landscape, Technology Landscape
July 2022
Landscape of innovative tools and delivery strategies for eliminating vertical transmission of HIV, syphilis, hepatitis B, and Chagas in endemic areas
Document Type
Technology Landscape
July 2022
Unitaid Audited Financial Report for the year ended 31 December 2021
Document Type
Financial Statement
June 2022
Transforming IPT for Optimal Pregnancy (TIPTOP) & the Supply Side Grant, Evaluation Summary
Document Type
Evaluations
June 2022
Joint end of project evaluation – HIV Self-Testing (HIVST) area for intervention, Executive Summary
Document Type
Evaluations
June 2022
Unitaid HIV Self Testing (HIVST) area for intervention, Joint end of project evaluation, Supplementary Appendices
Document Type
Evaluations
June 2022
Unitaid HIV Self Testing (HIVST) area for intervention – Joint end of project evaluation
Document Type
Evaluations
April 2022
Mid-term evaluation of Unitaid’s COVID-19 portfolio of investments
Document Type
Evaluations